Racial/Ethnic Disparities in Antiretroviral Treatment Among HIV-Infected Pregnant Medicaid Enrollees, 2005–2007
Bibliographic Data
Objectives. We examined racial/ethnic differences in prenatal antiretroviral (ARV) treatment among 3259 HIV-infected pregnant Medicaid enrollees. Methods. We analyzed 2005–2007 Medicaid claims data from 14 southern states, comparing rates of not receiving ARVs and suboptimal versus optimal ARV therapy. Results. More than one third (37.3%) had zero claims for ARV drugs. Three quarters (73.4%) of 346 Hispanic women received no prenatal ARVs. After we adjusted for covariates, Hispanic women had 3.89 (95% confidence interval = 2.58, 5.87) times the risk of not receiving ARVs compared with Whites. Hispanic women often had only 1 or 2 months of Medicaid eligibility, perhaps associated with barriers for immigrants. Less than 3 months of eligibility was strongly associated with nontreatment (adjusted odds ratio = 29.0; 95% confidence interval = 13.4, 62.7). Conclusions. Optimal HIV treatment rates in pregnancy are a public health priority, especially for preventing transmission to infants. Medicaid has the surveillance and drug coverage to ensure that all HIV-infected pregnant women are offered treatment. States that offer emergency Medicaid coverage for only delivery services to pregnant immigrants are missing an opportunity to screen, diagnose, and treat pregnant women with HIV, and to prevent HIV in children
Atomic oxygen · Hydrogen · Oxygen · Ozone · Atmospheric chemistry and aerosols · Atmospheric Ozone and Climate · Chemical Reactions and Isotopes · Chemistry
Latina Sexual Health Care (In) the Us
Management of infection among Medicare beneficiaries with HIV/Aids
An Investigation of Associations Between Race, Ethnicity, and Past Experiences of Discrimination with Medical Mistrust and Covid-19 Protective Strategies
Identifying a Sample of HIV-Positive Beneficiaries From Medicaid Claims Data and Estimating Their Treatment Costs
The Influence of Race and Comorbidity on the Timely Initiation of Antiretroviral Therapy Among Older Persons Living With HIV/Aids
HIV-Related Mortality Among Adults (≥18 years) of Various Hispanic or Latino Subgroups-United States, 2006-2010
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
Eight Americas
Health Care Access, Use of Services, and Experiences Among Undocumented Mexicans and Other Latinos
Estimation of HIV Incidence in the United States
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
Variations in the Care of HIV-Infected Adults in the United States
Factors in the Delayed HIV Presentation of Immigrants in Northern California
Disparities in Pregnancy Healthcare Utilization Between Hispanic and Non-Hispanic White Women in Rhode Island
Defining Urban and Rural Areas in U.S. Epidemiologic Studies
Racial, gender and geographic disparities of antiretroviral treatment among US Medicaid enrolees in 1998
Confronting the Moral Economy of US Racial/ Ethnic Health Disparities
Black–White Mortality From HIV in the United States Before and After Introduction of Highly Active Antiretroviral Therapy in 1996
Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
Comorbidity Measures for Use with Administrative Data
| Unique citing works | 6 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2014 - 2023 (10) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 6 |